Satsuma Pharmaceuticals, Inc.
Satsuma Pharmaceuticals, Inc. is a drug Delivery Tech for Migraine founded in 2016 by John Kollins.
2
Funding Rounds
$74.0m
Money raised
Overview
Satsuma Pharmaceuticals, Inc. is a drug Delivery Tech for Migraine founded in 2016 by John Kollins.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Ko***** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo** Ko***** | - | - | |
| Ke* Ta******* | - | - | |
| Mu*** Ha**** | - | - | - |
| Ra**** Sh** | - | - | |
| Mi***** Ri*** | - | - | - |
| El******* Sa****** | - | - | - |
| Th**** So***** | - | - | - |
| He*** Lu***** | - | - | |
| Th**** B. Ki** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Satsuma Pharmaceuticals, Inc. has raised a total of $74m in funding over 2 rounds.
Key Insights:
- Sasuma Pharmaceuticals , April 2019: $62m
- Satsuma Pharmaceuticals, Inc. Series A round, January 2017: $12m
Sasuma Pharmaceuticals , April 2019
$62m
Satsuma Pharmaceuticals, Inc. Series A round, January 2017
$12m
Industries
Satsuma Pharmaceuticals, Inc. is active in the following industries:
- Biology
- Biomedical engineering
- Technology
- Biotechnology
- Drug delivery
- Engineering